1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
PSA : role in screening and monitoring patients with prostate cancer
2022) p.131-172(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Automated Bone Scan Index to Optimize Prostate Cancer Working Group Radiographic Progression Criteria for Men With Metastatic Castration-Resistant Prostate Cancer
(
- Contribution to journal › Article
- 2020
-
Mark
Reply by Authors
(
- Contribution to journal › Article
-
Mark
Analysis of AR-FL and AR-V1 in Whole Blood of Patients with Castration Resistant Prostate Cancer as a Tool for Predicting Response to Abiraterone Acetate
(
- Contribution to journal › Article
- 2014
-
Mark
Analytic and clinical validation of a prostate cancer-enhanced messenger RNA detection assay in whole blood as a prognostic biomarker for survival
(
- Contribution to journal › Article
-
Mark
Organoid cultures derived from patients with advanced prostate cancer
(
- Contribution to journal › Article
- 2011
-
Mark
TMPRSS2-ERG Status in circulating tumor cells as a predictive biomarker of sensitivity in castration-resistant prostate cancer patients treated with abiraterone acetate
(
- Contribution to journal › Article
- 2009
-
Mark
Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer
(
- Contribution to journal › Article
-
Mark
Circulating prostate tumor cells detected by Reverse transcription-PCR in men with localized or castration-refractory prostate cancer : Concordance with CellSearch assay and association with bone metastases and with survival
(
- Contribution to journal › Article
- 2007
-
Mark
Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer
(
- Contribution to journal › Article